Entheon Biomedical Corp. filed its Annual on Mar 30, 2022 for the period ending Nov 30, 2021. In this report its auditor, Manning Elliott, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 CAD | 0.00% | -9.09% | +50.00% |
29/04 | Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
18/04 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+50.00% | 10L | |
+32.50% | 4.95TCr | |
+1.44% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.78% | 2.66TCr | |
-22.79% | 1.86TCr | |
+7.92% | 1.32TCr | |
+30.33% | 1.25TCr | |
+24.16% | 1.21TCr |
- Stock Market
- Equities
- ENBI Stock
- News Entheon Biomedical Corp.
- Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt